QuidelOrtho Corporation 0A55.L Stock
QuidelOrtho Corporation Price Chart
QuidelOrtho Corporation 0A55.L Financial and Trading Overview
QuidelOrtho Corporation stock price | 42.23 USD |
Previous Close | 85 USD |
Open | 0 USD |
Bid | 0 USD x N/A |
Ask | 0 USD x N/A |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 107.64 USD |
Volume | 351 USD |
Avg. Volume | 226 USD |
Market Cap | N/A |
Beta (5Y Monthly) | 0.287676 |
PE Ratio (TTM) | 0.03602692 |
EPS (TTM) | 23.62 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0A55.L Valuation Measures
Enterprise Value | 8.08B USD |
Trailing P/E | 0.03602692 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 1.1344521 |
Enterprise Value/Revenue | 2.6 |
Enterprise Value/EBITDA | 9.155 |
Trading Information
QuidelOrtho Corporation Stock Price History
Beta (5Y Monthly) | 0.287676 |
52-Week Change | -10.88% |
S&P500 52-Week Change | 20.43% |
52 Week High | 107.64 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 88.24 USD |
200-Day Moving Average | 88.37 USD |
0A55.L Share Statistics
Avg. Volume (3 month) | 226 USD |
Avg. Daily Volume (10-Days) | 46 USD |
Shares Outstanding | N/A |
Float | 50.54M |
Short Ratio | N/A |
% Held by Insiders | 7.07% |
% Held by Institutions | 96.19% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | January 1, 2023 |
Most Recent Quarter (mrq) | April 2, 2023 |
Next Fiscal Year End | January 1, 2024 |
Profitability
Profit Margin | 3.78% |
Operating Margin (ttm) | 16.12% |
Gross Margin | 52.82% |
EBITDA Margin | 28.39% |
Management Effectiveness
Return on Assets (ttm) | 5.27% |
Return on Equity (ttm) | 3.17% |
Income Statement
Revenue (ttm) | 3.11B USD |
Revenue Per Share (ttm) | 49.38 USD |
Quarterly Revenue Growth (yoy) | -15.59% |
Gross Profit (ttm) | 1.94B USD |
EBITDA | 883M USD |
Net Income Avi to Common (ttm) | 117.6M USD |
Diluted EPS (ttm) | 23.624 |
Quarterly Earnings Growth (yoy) | -89.79% |
Balance Sheet
Total Cash (mrq) | 408.5M USD |
Total Cash Per Share (mrq) | 6.13 USD |
Total Debt (mrq) | 2.82B USD |
Total Debt/Equity (mrq) | 56.47 USD |
Current Ratio (mrq) | 1.651 |
Book Value Per Share (mrq) | 75.023 |
Cash Flow Statement
Operating Cash Flow (ttm) | 573.3M USD |
Levered Free Cash Flow (ttm) | 404.25M USD |
Profile of QuidelOrtho Corporation
Country | United Kingdom |
State | CA |
City | San Diego |
Address | 9975 Summers Ridge Road |
ZIP | 92121 |
Phone | 858 552 1100 |
Website | https://www.quidelortho.com |
Industry | |
Sector(s) | |
Full Time Employees | 7000 |
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.
Q&A For QuidelOrtho Corporation Stock
What is a current 0A55.L stock price?
QuidelOrtho Corporation 0A55.L stock price today per share is 42.23 USD.
How to purchase QuidelOrtho Corporation stock?
You can buy 0A55.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for QuidelOrtho Corporation?
The stock symbol or ticker of QuidelOrtho Corporation is 0A55.L.
How many shares does QuidelOrtho Corporation have in circulation?
The max supply of QuidelOrtho Corporation shares is 0.
What is QuidelOrtho Corporation Price to Earnings Ratio (PE Ratio)?
QuidelOrtho Corporation PE Ratio is 0.01787589 now.
What was QuidelOrtho Corporation earnings per share over the trailing 12 months (TTM)?
QuidelOrtho Corporation EPS is 23.62 USD over the trailing 12 months.